{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:38Z","timestamp":1785412538654,"version":"3.56.0"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Universidad Cientifica del Sur","award":["066-2020-PRO99"],"award-info":[{"award-number":["066-2020-PRO99"]}]},{"name":"Universidad Cientifica del Sur","award":["059-2023-PRO99"],"award-info":[{"award-number":["059-2023-PRO99"]}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008441","name":"CYTED Ciencia y Tecnolog\u00eda para el Desarrollo","doi-asserted-by":"publisher","award":["221RT-0113"],"award-info":[{"award-number":["221RT-0113"]}],"id":[{"id":"10.13039\/501100008441","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Nacional de Investigaci\u00f3n Cient\u00edfica y Estudios Avanzados","award":["PE501082454-2023-PROCIENCIA"],"award-info":[{"award-number":["PE501082454-2023-PROCIENCIA"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,11,4]]},"abstract":"ABSTRACT<\/jats:title>\n \n \n \n The emergence and spread of third-\/fourth-generation cephalosporin and\/or carbapenem-resistant\n Acinetobacter baumannii<\/jats:italic>\n have become a significant global public health concern, making new treatment alternatives necessary. Thus, the present study aimed to assess\n in vitro<\/jats:italic>\n cefiderocol activity against clinical isolates of\n A. baumannii<\/jats:italic>\n and analyze their relationship with extended-spectrum \u03b2-lactamases (ESBLs) and carbapenemases. Ninety-five\n A. baumannii<\/jats:italic>\n clinical isolates were included in the study. Susceptibility to 12 antimicrobial agents was established by automated methods and\/or disk diffusion, while that of colistin was determined following microdilution and that of cefiderocol by microdilution using iron-depleted broth. The presence of\n bla<\/jats:italic>\n CTX-M<\/jats:sub>\n ,\n bla<\/jats:italic>\n PER<\/jats:sub>\n ,\n bla<\/jats:italic>\n VEB<\/jats:sub>\n ,\n bla<\/jats:italic>\n GES<\/jats:sub>\n ,\n bla<\/jats:italic>\n VIM<\/jats:sub>\n ,\n bla<\/jats:italic>\n IMP<\/jats:sub>\n ,\n bla<\/jats:italic>\n IMI<\/jats:sub>\n ,\n bla<\/jats:italic>\n KPC<\/jats:sub>\n ,\n bla<\/jats:italic>\n NDM<\/jats:sub>\n ,\n bla<\/jats:italic>\n OXA-23G<\/jats:sub>\n ,\n bla<\/jats:italic>\n OXA-24G<\/jats:sub>\n ,\n bla<\/jats:italic>\n OXA-48G<\/jats:sub>\n , and\n bla<\/jats:italic>\n OXA-58G<\/jats:sub>\n was established by PCR. The results showed extremely high levels of resistance (>80%) to all the tested antibacterial agents except colistin (11.6%) and cefiderocol (Clinical and Laboratory Standards Institute [CLSI]: 0%; US Food and Drug Administration [FDA]: 1.1%). Following FDA criteria, 22.1% of isolates were intermediate to cefiderocol, with 68.4% of isolates surpassing the European Committee on Antimicrobial Susceptibility Testing epidemiological cut off. Seven colistin-resistant isolates were only susceptible to cefiderocol following CLSI breakpoints, four of them qualifying as cefiderocol-intermediate following FDA breakpoints. No association between the presence of ESBLs or carbapenemases and cefiderocol minimum inhibitory concentration levels was observed. The present results show the potential utility of cefiderocol in the treatment of\n A. baumannii<\/jats:italic>\n infections, highlighting the need for judicious use and continuous surveillance to prevent the emergence of cefiderocol-resistant\n A. baumannii<\/jats:italic>\n clones.\n <\/jats:p>\n \n IMPORTANCE<\/jats:title>\n \n Antibiotic resistance is a silent pandemic challenging the treatment of infectious diseases worldwide, but also other medical practices, as, for instance, organ transplantation procedures. In Peru, current levels of antimicrobial resistance are worrisome. In this scenario, we have determined the\n in vitro<\/jats:italic>\n activity of cefiderocol against a series of\n Acinetobacter baumannii<\/jats:italic>\n exhibiting high levels of resistance to commonly used antibiotics. This activity is independent of the presence of the most common extended-spectrum beta-lactamases or carbapenemases. Obtained results showed the potential of cefiderocol to become an alternative for the treatment of this type of microorganism, but the high number of isolates bordering the considered breakpoint, despite the lack of use of cefiderocol in the country, also shows the need for a prudent use of this antibiotic to maximize its utility while minimizing the selection of resistant isolates.\n <\/jats:p>\n <\/jats:sec>\n <\/jats:sec>","DOI":"10.1128\/spectrum.00844-25","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:48:31Z","timestamp":1759920511000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["In vitro<\/i>\n activity of cefiderocol against nosocomial\n Acinetobacter baumannii<\/i>"],"prefix":"10.1128","volume":"13","author":[{"given":"Barbara","family":"Yma\u00f1a","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ego\u00e1vil-Espejo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Huerto-Hu\u00e1nuco","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Oporto-Llerena","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla A.","family":"Alonso","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos, Laboratorio de Microbiolog\u00eda, Hospital Universitario San Pedro","place":["Logro\u00f1o, Spain."]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie K.","family":"Castillo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano A.","family":"Palomino-Kobayashi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Valera-Krumdieck","sequence":"additional","affiliation":[{"name":"Servicio de Patolog\u00eda Cl\u00ednica \u00e1rea Microbiolog\u00eda, Hospital Mar\u00eda Auxiliadora","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Soza","sequence":"additional","affiliation":[{"name":"Instituto Nacional Materno Perinatal","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamin","family":"Ortiz-Gomez","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda y Biolog\u00eda Molecular, Laboratorios AUNA","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda, Hospital Mar\u00eda Auxiliadora","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"L\u00f3pez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03vfjzd38","id-type":"ROR","asserted-by":"publisher"}],"name":"\u00c1rea de Microbiolog\u00eda Molecular, Centro de Investigaci\u00f3n Biom\u00e9dica de La Rioja","place":["Logro\u00f1o, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Salvador-Luj\u00e1n","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02bx25k35","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratorio de Microbiolog\u00eda, Hospital Militar Central","place":["Lima, Peru"]},{"id":[{"id":"https:\/\/ror.org\/01t466c14","id-type":"ROR","asserted-by":"publisher"}],"name":"Facultad de Ciencias Biol\u00f3gicas, Universidad Nacional, Mayor de San Marcos","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-0980","authenticated-orcid":false,"given":"Beatriz","family":"Rojo-Bezares","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03vfjzd38","id-type":"ROR","asserted-by":"publisher"}],"name":"\u00c1rea de Microbiolog\u00eda Molecular, Centro de Investigaci\u00f3n Biom\u00e9dica de La Rioja","place":["Logro\u00f1o, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Casapia","sequence":"additional","affiliation":[{"name":"Hospital Regional de Loreto","place":["Iquitos, Peru"]},{"id":[{"id":"https:\/\/ror.org\/05h6yvy73","id-type":"ROR","asserted-by":"publisher"}],"name":"Facultad de Medicina Humana, Universidad Nacional de la Amazonia Peruana","place":["Iquitos, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Toledano","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03vfjzd38","id-type":"ROR","asserted-by":"publisher"}],"name":"\u00c1rea de Microbiolog\u00eda Molecular, Centro de Investigaci\u00f3n Biom\u00e9dica de La Rioja","place":["Logro\u00f1o, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pinto","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n B\u00e1sica y Traslacional Auna Ideas","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ramos","family":"Chirinos","sequence":"additional","affiliation":[{"name":"Instituto Nacional Materno Perinatal","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-4258","authenticated-orcid":true,"given":"Yolanda","family":"S\u00e1enz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03vfjzd38","id-type":"ROR","asserted-by":"publisher"}],"name":"\u00c1rea de Microbiolog\u00eda Molecular, Centro de Investigaci\u00f3n Biom\u00e9dica de La Rioja","place":["Logro\u00f1o, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-2315","authenticated-orcid":true,"given":"Maria J.","family":"Pons","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-2036","authenticated-orcid":true,"given":"Joaquim","family":"Ruiz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xr5we72","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaci\u00f3n en Din\u00e1micas y Epidemiolog\u00eda de la Resistencia a Antimicrobianos - \u201cOne Health\u201d, Universidad Cient\u00edfica del Sur","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-023-00445-y"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10393-025-01712-2"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2024.880-887"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trab186"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.11.007"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.02.023"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S319780"},{"key":"e_1_3_3_9_2","unstructured":"O\u2019Neill J. 2016. Tackling drug-resistant infections globally: final report and recommendations. Available from: https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.21142\/SS-0101-2020-001"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2021.0015"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad556"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-013-0495-y"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/00494755221142939"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.22-0556"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101034"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.37201\/req\/s02.02.2022"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae169"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01474-24"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae367"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0127-9"},{"key":"e_1_3_3_24_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2025. Clinical breakpoints (v 15.0). Available from: https:\/\/www.eucast.org\/clinical_breakpoints. Retrieved 22 Jul 2025."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-002104"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jphsr\/rmad015"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.22354\/in.v24i4.876"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa060"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.11.005"},{"key":"e_1_3_3_30_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2025. Data from the EUCAST MIC distribution website. Available from: https:\/\/www.eucast.org. Retrieved 12 Jan 2025."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00379-25"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00832-25"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.17843\/rpmesp.2021.381.5882"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.17843\/rpmesp.2020.372.4747"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00877-21"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab888"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44155-025-00225-1"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11112721"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.17843\/rpmesp.2023.403.12721"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.17843\/rpmesp.2019.362.4152"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091168"},{"key":"e_1_3_3_42_2","first-page":"115","volume-title":"Nucleic acid techniques in bacterial systematic","author":"Lane DJ","year":"1991","unstructured":"Lane DJ. 1991. 16S\/23S rRNA sequencing, p 115\u2013175. In Stackebrandt ER, Goodfellow M (ed), Nucleic acid techniques in bacterial systematic. John Wiley and Sons, Chichester (UK)."},{"key":"e_1_3_3_43_2","volume-title":"Supplement M100-S31","author":"Clinical and Laboratory Standards Institute","year":"2021","unstructured":"Clinical and Laboratory Standards Institute. 2021. Performance standards for antimicrobial susceptibility testing. In Supplement M100-S31. CLSI, Wayne."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.21142\/SH-01-2024-e008"},{"key":"e_1_3_3_45_2","unstructured":"US Food and Drug Administration (FDA). 2025. Cefiderocol injection. Available from: https:\/\/www.fda.gov\/drugs\/development-resources\/cefiderocol-injection. Retrieved 22 Jan 2025."},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt065"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl481"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.29314"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.06.011"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00844-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00844-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:10:27Z","timestamp":1762265427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00844-25"}},"subtitle":[],"editor":[{"given":"Ayesha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,4]]}},"alternative-id":["10.1128\/spectrum.00844-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00844-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"2025-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00844-25"}}